Replies to post #165840 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

Notable posts - 09/18/18 (edit)

Since mods only have one sticky I'm going to make this one count, LOL!

Hampel SPEAKS!....
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142864055

An excellent summary of why we are here from poster sokol:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143320176

Basic biology concepts for Alzheimer’s disease
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=137348423

Dangerous medicines and mitochondrial dysfunction:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142393634&txt2find=mitochondrial

Shareholder meeting report:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140128467&txt2find=shareholder|meeting

Special Protocol Assessment:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140087471

Did BIIB blink?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143525102

Perspective on how quickly Anavex could morph into a profitable entity, making further dilution unnecessary. This may provide urgency for institutions to establish a position where stock has limited liquidity resulting in a pre-approval ramp up of pricing.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143560772

How the Parkinson's Dementia trial may help expedite Alzheimer's approval:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143580569

AVXL 2-73 and cerebral blood flow:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143582952

Two arguments for accelerated approval for 2-73.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143620275
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143624077